Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Antibe Therapeutics Inc(Pre-Merger)
ATBPF
Healthcare
Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug,...
otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (GREY:ATBPF)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(128)
•••
MrMugsy
X
View Profile
View Bullboard History
Comment by
MrMugsy
on Mar 08, 2024 8:07pm
RE:RE:RE:Lots of Questions
Still here - trying to understand all the options and what it takes to get P2 completed.
(8)
•••
Montana5
X
View Profile
View Bullboard History
Comment by
Montana5
on Mar 08, 2024 5:29pm
RE:RE:Lots of Questions
Insider buys March 6/7: Curtis 15,000 shares @ $.52 Legault 20,000 shares @ $.50 Stauffer 24,000 shares @ $.40 USD Not exactly mortgaging the house, but better than nothing. Curious as to where they
...more
(55)
•••
Harper75
X
View Profile
View Bullboard History
Comment by
Harper75
on Mar 08, 2024 10:32am
RE:Lots of Questions
IMO the total silence from Antibe leadership is astounding.
(1093)
•••
Duster340
X
View Profile
View Bullboard History
Post by
Duster340
on Mar 08, 2024 10:17am
Lots of Questions
but no answers = uncertainty and a lower stock price
(1093)
•••
Duster340
X
View Profile
View Bullboard History
Post by
Duster340
on Mar 07, 2024 11:01am
Waiting for the next shoe 👞
to drop, white knuckle time for investors lol
(1093)
•••
Duster340
X
View Profile
View Bullboard History
Post by
Duster340
on Mar 07, 2024 8:11am
Todays news release
a big nothing burger
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Mar 07, 2024 7:01am
New Press Release - Antibe to Present Otenaproxesul PK/PD Results at the American Academy of Pain Medicine Meeting
- AAPM is the primary organization for pain medicine physicians in the U.S. Antibe Therapeutics Inc. (TSX: ATE, OTCQX: ATBPF), a clinical-stage biotechnology company leveraging its hydrogen sulfide platform to target pain and inflammation, is pleased to announce a poster presentation of data...
read article.
(1093)
•••
Duster340
X
View Profile
View Bullboard History
Post by
Duster340
on Mar 06, 2024 1:20pm
RE:RE:I see davgro
only management has all the facts, that drop down to 40cents scared the krap out of me, and i was only to happy to sell them all on the surprise bounce back, even made a profit. i am now on the
...more
(55)
•••
Harper75
X
View Profile
View Bullboard History
Comment by
Harper75
on Mar 06, 2024 1:06pm
RE:I see davgro
Do you have all the facts on what is happening behind the scenes? TBH - I'm waffling between company will be sold off for IP to major dillution to fund Phase 2. Sure would love some
...more
(1093)
•••
Duster340
X
View Profile
View Bullboard History
Post by
Duster340
on Mar 06, 2024 11:44am
I see davgro
shows up just in time to put his foot in his mouth again lol too funny, obviously he does not have all the facts of what is going on behind the scenes. nice bounce back from 40 cents this morning
...more
(1093)
•••
Duster340
X
View Profile
View Bullboard History
Post by
Duster340
on Mar 06, 2024 11:17am
You Guys
spoke to soon LMFAO
(10)
•••
JPkatz
X
View Profile
View Bullboard History
Post by
JPkatz
on Mar 06, 2024 10:40am
One thing is for sure
Dan will go down as one of the worst ceo's in history!!! He's done nothing right, literally one blunder after another while bleeding shareholders dry! What else would you
...more
(450)
•••
davgro
X
View Profile
View Bullboard History
Comment by
davgro
on Mar 06, 2024 10:40am
RE:RE:I'm sorry what happened?
Its a lot worse than investors understand. The judgement was $24 million in USD or the equivalent of about $32 million in CAD. Terms of payment are unknown but I would expect that payment
...more
(2)
•••
Muddyork
X
View Profile
View Bullboard History
Post by
Muddyork
on Mar 06, 2024 10:27am
Another haircut?
Whats with today? All the shareholders that missed the Monday memo?? Haven't seen anything from the Antibe camp yet, have you?
(376)
•••
woundedknee
X
View Profile
View Bullboard History
Comment by
woundedknee
on Mar 06, 2024 9:49am
RE:I'm sorry what happened?
Wow! ATE has to repay 20 million plus 4 million interesr and not subject to appeal. This story just keeps getting better and better,,,for the shorts. GL Mugsy
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >